Frida Kahlo, Corporeal field , 1946

Investment Thesis: 📝
 

Metric	Value
Investment Horizon	2–4 Years (Target Exit 2028–2030)
Potential Net ROI p.a. (Balanced)	17.0% p.a.
Potential Net ROI p.a. (Ambitious)	38.1% p.a.
Sharpe Ratio	0.81 (Above SMI 5Y benchmark: 0.61)
Value at Risk (VaR)	93.4% probability to exceed invested capital after 4 years
Standard Deviation	19.6%
Entry Discount (Pre-Fees)	-11.5% vs. current market value
Entry Discount (Post-Fees)	-7.1% vs. current market value
Comparable Sales Used	8 Main Comparable Sales
Final Rating	A (8.8 / 10)

 

• 17% balanced return: Based on ~85% probability of achieving a 22% CAGR (2019–2025 comparables).
• 38.1% ambitious return: Based on ~40% probability of achieving 102% CAGR (2024–2025 peak cycle comparables).
• 93.4% VaR protection: High statistical probability of capital preservation over 4 years.
• Sharpe 0.81: Attractive risk-adjusted performance, above SMI benchmark.
• 19.6% volatility: Moderate and controlled compared to broader collectible segments.
• -11.5% acquisition discount: Immediate valuation cushion enhances downside protection.
• Grade A (8.8/10): Strong balance of return potential, scarcity, and statistical resilience.

Why Invest in This Category? 🎨

---

Investing in blue-chip art offers exposure to stable, historically appreciating assets with global demand and limited supply. These works combine cultural relevance with proven market performance, often outperforming traditional investments during economic cycles while providing diversification, inflation protection, and enduring value anchored in artistic legacy.

Why Invest in This Asset? 💎

---

Investing in Corporeal Field (c. 1946) means acquiring a rare and intimate work by Frida Kahlo at a decisive turning point in her life and artistic evolution. In June 1946, following a major spinal surgery in New York—one of more than thirty operations she endured—Kahlo entered the most severe physical phase of her life. That surgery was not a cure; it was a threshold. From this moment onward, her art shifted dramatically: outwardly composed self-portraits gave way to an unfiltered exploration of interior pain. Beauty no longer concealed suffering—pain became the language.

Works from this period capture the transformation of physical trauma into visual philosophy. Beginning in 1946, Kahlo developed a more introspective form of self-portraiture, where the body itself—its spine, nerves, and vulnerability—became central. Paradoxically, this deepening personal struggle coincided with national recognition, including her 1946 honor at Mexico’s Palace of Fine Arts. Decline and consecration unfolded simultaneously, shaping the myth that defines her legacy. Kahlo’s market is structurally defined by extreme scarcity. With roughly 150 known works, supply is permanently constrained, and her output was limited by lifelong medical hardship. Institutional demand remains consistently strong, supported by global exhibitions, scholarship, and the enduring cultural power of her biography.

Works on paper from this late phase are particularly compelling: intimate, psychologically charged, and closely aligned with the emotional core of her practice. As museums and major collectors compete for museum-quality examples, opportunities to acquire authenticated works from this decisive period remain exceptionally limited—positioning Corporeal Field as both a cultural landmark and a historically anchored investment asset.

Conclusion 🎯

---

Corporeal Field unites structural scarcity with profound emotional intensity and institutional relevance. As one of the rare surviving works from Kahlo’s decisive late period, it captures a moment where personal suffering crystallized into artistic immortality. Its authenticity, historical significance, and sustained global demand position it as a museum-caliber, blue-chip acquisition for sophisticated collectors seeking both cultural legacy and enduring value.